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Nowadays the use of gel containing carbamide peroxide (CP) prepared in Pharmacy is a normal practice 
in the population. However, the quality of this product is questionable concerning its stability. The aim 
of this study is was to synthesize and to analyze this drug alone or associated to Carbopol gel through 
analytical methodology compatible with the routine of the Pharmacies. The reaction between urea and 
hydrogen peroxide was carried out at different resting times: 24 hours (CP 24 powder) and 48 hours (CP48 
powder) after the mixture. Both products were associated with Carbopol 940® gel 1.5% (G) generating 
G24 and G48 samples. The stability of powders (CP24 e CP48) and the formulations (G24 and G48) 
were evaluated as a function of time (15, 40 and 45 days) and thermal variation (refrigeration: 8 °C±1; 
thermal shock 32 °C±1 /8 °C±1; stove: 32 °C±1), using a standard titration method. As a result, only under 
refrigeration the CP24 and CP48 contents remained stable during the period of 45 days. An interesting 
finding was that G24 and G48 presented greater stability for at least 45-days under refrigeration and 
thermal shock conditions, and up to 30 days under stove conditions. The results for the G24 and G48 were 
slightly higher than those obtained for the control. Therefore, we were able to conclude that association 
with Carbopol 940® Gel 1.5 % provided greater CP stability and that manipulated formulations containing 
CP may be viable for use in a period of 45 days under refrigeration conditions. The titration proved to 
be an effective technique for the analysis of CP with or without Carbopol 940® gel 1.5%.
Uniterms: Carbamide peroxide/quantitative analysis. Carbamide peroxide/stability. Dental bleaching. 
Carbopol 940® gel 1.5%.
Atualmente, a utilização de gel contendo peróxido de carbamida manipulado em Farmácia é uma 
prática comum na população. No entanto, a qualidade deste produto é questionada, sobretudo no que 
se refere à estabilidade deste fármaco. O objetivo deste trabalho consiste na avaliação da viabilidade de 
sintetizar e analisar quantitativamente este fármaco associado ou não a um gel de Carbopol através de 
metodologia analítica compatível com a rotina das Farmácias. A reação entre a uréia e o peróxido de 
hidrogênio foi realizada em tempos diferentes de repouso após a mistura, 24 h para sintetizar o pó PC 
24 e 48 h para o pó CP 48. Estes pós foram associados a um gel (G) de Carbopol 940® 1,5 %, originando 
as amostras G24 e G48. A estabilidade dos pós (PC 24 e PC 48) e das formulações (G 24 e G 48) foi 
avaliada em função do tempo (15, 40 e 45 dias) e da variação térmica (refrigeração: 8 °C±1; choque 
térmico: 32 °C±1/8 °C±1 e estufa: 32 °C±1), através da técnica de titulometria. Os resultados indicam 
que unicamente sob refrigeração o CP24 e o CP 48 mantiveram-se estáveis no período de 45 dias. O G24 
e o G48 apresentaram estáveis por pelo menos 45 dias nas condições de refrigeração e choque térmico e 
por 30 dias na condição estufa. Os resultados obtidos para o G24 e G48 foram ligeiramente superiores aos 
obtidos para o controle. Além disso, é possível concluir que a associação do PC com o gel de Carbopol 
940® 1,5 % promoveu um aumento na estabilidade do PC e que as preparações manipuladas contendo PC 
são viáveis para uso durante um período de 45 sob refrigeração. A titulometria mostrou-se uma técnica 
eficaz para a análise do PC associado ou não ao gel de Carbopol 940® 1,5 %.
Unitermos: Peróxido de carbamida/análise quantitativa. Peróxido de carbamida/estabilidade. Clareamento 
dental. Gel de Carbopol 940®.
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INTRODUCTION
Recently, dental bleaching procedures became 
more popular as a result of the increasing awareness of 
the importance of having healthy white teeth (Gordon, 
Chiritensen, 2005). Dental darkening may be caused by 
extrinsic factors (e.g. smoking, food or beverages with pig-
ments), or intrinsic factors either congenital (e.g. imperfect 
dentinogenesis) or acquired (e.g. use of tetracyclines, fluo-
rine or trauma) (Goldstein, 2000). Nowadays, two bleach-
ing techniques are commonly used. The home-bleaching 
technique implies on using a low concentration of CP gel 
dental strips for an average period of 2 to 3 weeks, and 
is becoming increasingly popular. On the other hand, the 
office technique, although older, was not frequently used 
until recently due to the difficulties associated with the 
hydrogen peroxide solution application and the need for 
absolute isolation (Papathanasiou et al., 2002; Wetter et 
al., 2009).
The carbamide peroxide (CP), also known as urea 
peroxide, hydrogen peroxide-urea or urea-peridrol, was 
initially used as an anti-inflammatory in the great wars to 
treat periodontal diseases (Gonçalvez et al., 2001; Gratão 
et al., 2003). Starting in 1960, it has been used in the form 
of antiseptic solutions (10 % CP) for the treatment of gin-
givitis in children and adults by the orthodontist William 
Klusmier, in which the tooth whitening occurred as a side 
effect of the anti-septic property. After this event, in 1989, 
Haywood and Heymann published the first article about 
tooth whitening with CP at concentrations ranging from 10 
% to 20 % (Gonçalvez et al., 2001; Compoy et al., 2001; 
Goldstein, 2000).
The action mechanism of bleaching consists in the 
oxidation reaction of the CP bleaching agent, which in 
contact with the saliva or gingival tissue is broken down 
into hydrogen peroxide and urea. The urea produces 
ammonia and carbon dioxide, contributing to the mainte-
nance of an alkaline pH, which potentiates the action of 
the bleaching agent (Sun, 2000). The hydrogen peroxide 
diffuses through the organic matrix of enamel and dentin, 
releasing free radicals that break O2 carbon rings of high 
molecular weight from darker pigmentation, converting 
them into clearer smaller molecules (Compoy et al., 2001; 
Rodrigues et al., 2005; Goldberg et al., 2009). Neverthe-
less, for bleaching gel to act on enamel and dentin, it is 
necessary for it to diffuse through the dental tissues. It is 
known that the greater the surface tension of a liquid, the 
lower its ability to diffuse through a surface or to wet it. Af-
ter the bleaching treatment changes have been observed in 
surface texture (Potocnik et al., 2000) mineral content (At-
tin et al., 2005), chemical composition (Justino, Demarco, 
2004) and loss by tooth brushing abrasion (Wiegand, Attin, 
2004). The addition of surfactants to hydrogen-peroxide-
based bleaching gel resulted in a significantly more exten-
sive bleaching (Canepelle, Torres, 2011).
The other application for CP is in the treatment for 
plaque, gingival health and caries, so antibacterial activity 
has been studied (Nunes et al., 2011). Plaque accumulation 
and resulting caries or periodontal disease is a frequent 
problem in patients with special-care needs. Lazarchik and 
Haywoode reviewed in 2010 the antibacterial properties 
of CP and the effects of CP on saliva, plaque, caries and 
gingival health. They addressed the challenges involved 
in the research needed regarding the use of tray-applied 
CP materials in special-care patients. The results showed 
that CP at 10 % may be a great promise for improving the 
oral health of many special-care patients, including elderly 
patients, patients with cancer and patients with dry mouth.
The technique described by Haywood and Hey-
mann was improved when the CP was associated with the 
Carbopol® gel at 1.5 %. Carbopol is a thickening agent, 
of thixotropic nature, used in the process to stabilize the 
dissociation of the bleaching agent, releasing oxygen 
more slowly, increasing the time of action of the product 
formulation and adhesion to tooth structure (Compoy et 
al., 2001; Apple, Reus, 2003). 
The bleaching agents, however, are chemically very 
unstable (Baratieri et al., 2004). The commitment of their 
stability is related to factors such as temperature, light, 
moisture, pH, impurities and others (Ansel et al., 2000). 
Thus, stability tests to predict monitoring and to determine 
the validity and the ideal storage conditions are needed.
The products used for dental bleaching could be pre-
pared by the industry and by the pharmacist. The manipu-
lated products have questionable quality, because of the 
low stability of CP. Therefore, the studies about applicable 
analytical methodologies in pharmacy practice contribute 
to the quality certification of the products.
The aim of this work was to analyze the synthesis 
of CP, through the reaction of hydrogen peroxide and urea 
for 24 and 48 hours and subsequent percentage evaluation 
of CP in the synthesized product. Moreover, the work was 
to study the incorporation of active Carbopol 940® gel at 
1.5 % and stability evaluation of both the CP and the CP 
gel as a function of time and temperature variation, with 
the aim to establish a protocol for monitoring its adaptive 
stability reality of pharmacies.
METODOLOGY
The CP was synthesized using urea (All Chemistry) 
and hydrogen peroxide 130 V (All Chemistry) in equal 
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proportions. Urea was crushed in porcelain mortar and 
then hydrogen peroxide 130 V was added. The mixture 
was divided into two portions, covered with plastic wrap 
and kept at rest for 24 h and 48 h respectively, in the dark, 
resulting in the samples CP24 and CP48. After this period, 
both portions were vacuum filtered and the solids were 
stored in desiccators for 24 hours (USP 27 2004; Zanardi 
et al., 2007).
For the Carbopol 940® gel at 1.5 % containing CP 
preparation, 16 % of CP24 was incorporated, taking into 
account its level, in 60 % Carbopol 940â gel at 1.5 %. It 
was also added 0.3 % of sodium fluoride as a desensitizing 
agent. The same procedure was repeated for CP48, result-
ing in samples G24 and G48, respectively. The controls 
used for this experiment consisted of CP in the dust from 
Merck (Dust Control) and the gel of CP 16 % of Whiteness 
Perfect® (FGM Control).
Samples CP24, CP48, G24 and G48 and controls 
were stored in bottles, milky plastic and syringes re-
spectively sealed, and then exposed to three different 
temperature conditions for the experiment: a) Thermal 
Shock: 32 °C±1 /8 °C±1 °C; b) Stove: 32 °C±1 °C and c) 
Refrigeration: 8±1 °C.
The CP determination in the samples and controls, 
stored under different conditions, was done by quantitative 
iodometric (titrimetric), taking as a basis the methodology 
described in the United States Pharmacopeia (USP 27, 
2004). It was done in triplicate at predetermined dates, 
divided into 4 different times totaling 45 days. Then, 
100.00 mg of CP were weighed, and this amount was 
transferred to an Erlenmeyer flask of 500 mL. For the gel, 
625.00 mg were weighed on a CP 500 mL flask, which 
corresponds to 100.00 mg of CP. Later, distilled water, 
acetic acid PA, potassium iodide and sodium molybdate 
10% (aqueous solution) were added. The solution was 
homogenized and then maintained under light for 10 min. 
The liberated iodine was titrated with aqueous 0.05 M 
sodium thiosulfate TS. Near the turning point, 3.00 mL of 
2% starch indicator were added, changing the color from 
dark blue to colorless. 
Considering that each mL of 0.05M sodium thiosul-
fate TS is equivalent to 4.704 mg of CP, the concentration 
percentage was calculated for the samples and controls. 
The average return and standard deviation of the results 
were calculated. The effects of different storage conditions 
(8 °C ± 1; 32 °C / 8° C ± 1; 32 °C ± 1), time (15, 30 and 
45 days), formulation (G24, G48 and Control) and their 
interactions were assessed using factorial design analysis 
for three factors by ANOVA followed by Tukey post-test 
(a = 0.05). It was used SPSS (Statistical Package for the 
Social Sciences) 17.0 for Windows.
RESULTS AND DISCUSSION
Table I shows the results of the CP content in the 
samples and controls, obtained by titrimetric assay at dif-
ferent temperature conditions in which they were exposed 
for a period of 45 days.
The concentration of CP in the samples CP24, CP48 
and control at time zero (after preparation), showed an 
average concentration of 98.31%, 99.01% and 97.85%, 
respectively (Table I); values were considered within phar-
macopoeial limits of 96% to 102 (USP 27, 2004), with no 
significant statistically difference between them (tukey test, 
p< 0.05). Threshold values of concentration of CP gel incor-
porated into Carbopol 940® were not found in the literature.
TABLE I - Evaluation of CP content in the powder and gel pharmaceutical forms under different temperature conditions
Samples
CP Content (%) ± S.D
After 
preparation (AP)
(Zero Time)
8 °C±1 32 °C±1/ 8 °C±1 32 °C±1
Days Days Days
15 30 45 15 30 45 15 30 45
CP24 98.31 ± 0.44 98.27 ± 0.19 96.67 ± 0.36 96.04 ± 0.50 94.67 ± 0.14 68.42 ± 0.40 35.35 ± 0.85 1.41 ± 0.02 - -
CP48 99.01 ± 0.88 98.24 ± 0.84 96.87 ± 0.34 95.22± 0.32 93.70 ± 0.44 69.06± 0.09 35.37 ± 0.40 1.40 ± 0.04 - -
Merck® 
Control 
(powder)
97.85 ± 0.49 97.18 ± 0.73 96.39± 0.41 95.24± 0.35 96.87± 0.24 95.59 ± 0.31 92.66 ± 0.79 97.70 ± 0.40 94.42 ± 0.21 92.28 ± 036
G24 100.39 ± 0.64 101.40 ± 0.25 100.90 ± 0.31 100.25 ± 0.50 99.73 ± 0.50 98.08 ± 0.63 96.21 ± 0.29 99.79 ± 0.04 97.19 ± 0.27 94.00 ± 0.32
G48 100.16 ± 0.58 101.40 ± 0.31 100.25 ± 0.00 99.73 ± 0.47 101.00 ± 0.77 99.48 ± 0.29 97.02 ± 1.81 98.92 ± 1.16 96.07 ± 0.27 89.89 ± 0.28
FGM Control 
(gel)
99.75 ± 0.55 99.26 ± 0.39 98.76 ± 1.04 98.57 ± 0.42 99.59 ± 0.27 97.70 ± 0.08 95.37 ± 1.12 97.22 ± 0.35 91.35 ± 1.01 89.29 ± 0.75
CP: carbamide peroxide; CP24: carbamide peroxide powder after 24 h; CP48: carbamide peroxide powder after 48 h; G24: carbamide peroxide gel containing 
CP24; G48: carbamide peroxide gel containing CP48.
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The results demonstrated in Table I showed that the 
samples CP24 and CP48 in the refrigeration condition 
(8 °C ± 1) had no statistical difference compared to their 
control at time zero, 15 and 30 days (tukey test, p< 0.05). 
However, in 45 days the CP48 and control showed a sig-
nificant CP decrease of 3.79 % and 2.61 % respectively 
(Table I): This decrease is within the acceptable limit 
variation of 5 % in stability studies recommended in RE 
nº1.5 (Brazil, 2005).
Regarding the heat shock condition (32 °C ± 1 / 
8 °C ± 1), the CP24 control remained stable during the first 
15 days, differing from CP48. After 45 days of exposure, 
the CP24 and CP48 samples showed a decrease in the CP 
levels of 64 %. Only the control remained stable with a 
reduction of only 5.2 %.
In stove conditions (32 °C ± 1), CP24 and CP48 
samples showed a substantial decrease in the CP level that 
started at 15 days of exposure, resetting the CP content 
over time. This may be related to the decomposition of 
CP in ammonia (urea), oxygen and water (hydrogen per-
oxide) at temperatures above 30 °C (Gratae et al., 2003; 
Basting, 2006; Leonard et al., 1994). The dust control in 
this condition showed a slight CP decrease after 30 days, 
but remained constant at the end of 45 days. This ambigu-
ity of behavior for the CP24 and CP48 in comparison to 
controls, tested under different conditions can be attributed 
to different experimental conditions in the methods of 
obtaining these substances. The resolution RE nº 01/05 on 
pharmaceutical active establishes that stability depends on 
temperature, humidity, light and other factors relating to 
the product itself (physical and chemical properties). In 
addition, one must consider other aspects that can interfere 
with stability of assets such as: presence or absence of 
excipients, the dosage form type, manufacturing process 
and material packaging (Brazil, 2005).
The samples containing the CP associated with the 
Carbopol 940® gel 1.5 % (G24 and G48), when subjected 
to cooling showed statistical difference in CP content, 
when compared to control.
With regard to exposure of the same samples to heat 
shock (32 °C ± 1 / 8 °C ± 1), it was found that all samples 
were stable during the first 15 days. After 30 days, the G24 
had a decreased percentage of CP which was not observed 
for G48 and control. In 45 days the G24 was the formula-
tion that showed the most reduced levels of CP; however, 
this reduction was not significant, indicating stability of 
these formulations at the end of 45 days. The control gel at 
the end of 45 days showed a content change, demonstrat-
ing the instability of this vehicle in the tested condition. 
The G48 formulation was stable for 45 days on the studied 
condition temperature.
The display results under stove (32 °C ± 1) showed 
that the increase in temperature led to a decreased CP per-
centage after 30 days for all samples; however, this reduc-
tion was more significant for the control FGM (8.40%). 
After 45 days, there was a reduction of 6.39 % for G24, 
10.27 % for G48 and 10.46 % for the control. According to 
Aulton (2005) such behavior is expected due to the drastic 
conditions of storage. Increasing the temperature at 10 °C 
produces a 2-5 fold increase in the drugs degradation.
Figure 1 shows the statistical analysis of the gel 
containing CP in the different experimental conditions 
(time, storage conditions and formulation). Factor analysis 
applied significant difference p (probability values) <0.01 
for the main factors by the ANOVA for three factors. The 
comparison of means by Tukey test (a = 0.05) has shown 
that the storage of CP gel at low temperatures (8 ± 1 ºC) 
is more appropriate, and therefore recommended it as 
the condition for storage of the Carpobol 940®gel 1.5 % 
containing CP. It is possible to verify that the temperature 
exerts a strong influence on the CP decay associated to 
Carpobol 940®gel 1.5 %. Higher temperatures cause 
oscillation of the decay of this drug. This influence can 
be observed mainly for the CP powder. It is possible to 
show that the drug contents decrease as a function of time, 
since the observed differences are significant fortnightly. 
This observation is particularly useful for estimating an 
expiration date for the compounded product, through the 
results one can estimate a validity of at least 45 days for 
the product stored in the refrigerator.
A comparison of results between the G24, G48 and 
FGM control in different conditions, demonstrated that 
the G24 e G48 showed higher CP content than the control. 
This result is positive in demonstrating that manipulated 
formulations were similar to industrialized formulations, 
setting the feasibility and safety in the preparation of this 
formulation in masterful scale. Considering the results for 
the G24 and G48, one can realize that the time of synthesis 
of CP is not directly influenced by the quality of the final 
product, since there was no significant difference in CP 
content for these samples.
Considering these results, it was possible to show a 
greater reduction in CP level in powder than in Carbopol 
940® gel 1.5 %. Studies that evaluate the stability of the 
drug in isolated solid state and in the presence of excipi-
ents are important during the stage of pre-formulation of a 
product. Studies of stability of the formulation as a whole 
prioritize the evaluation of the drugs behavior over time 
considering the drug, the mixture of excipients or used 
vehicles, as well as the interaction between them, in dif-
ferent conditions (Brazil, 2005; Mamede et al., 2006). The 
present results have highlighted the importance that the 
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FIGURE 1 - Results of percentage of the major factors evaluated. 
Values represent the mean of each level and the associated error 
bars.
dosage form provides to the system as a whole, protect-
ing the active ingredient from degradation caused by the 
agents tested (Baratieri et. al., 2004).
CONCLUSION
In relation to the CP synthesis, one can say that it 
was feasible to carry it through because it is an easy and 
affordable methodology. Based on the temperature con-
ditions described and in accordance with the valuation 
method (titration), the results showed that the best form 
of storage for the CP dust is under refrigeration (8 ° C ± 
1), since the results indicate no significant decrease in CP 
levels when exposed to this condition. The association of 
CP in the Carbopol 940® gel 1.5 % provided greater CP 
stability, showing the importance of the dosage form in the 
protection of the active substance, having no significant 
difference between samples prepared with synthesized CP 
at different times.
This paper presented relevance with regard to its 
applicability in monitoring the CP content in powder and 
Carbopol 940â gel 1.5 % to be easily adapted into a phar-
macy routine. Thus, it can be ensured that the manipulated 
formulations in the Carbopol 940â gel at 1.5 % containing 
CP are viable for use in a period of 45 days when stored 
under refrigeration.
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